NTI | bio (Nuclear Threat Initiative - Biological Program)
NTI | bio (Nuclear Threat Initiative - Biological Program)
The biosecurity division of the Nuclear Threat Initiative, NTI | bio works to reduce global catastrophic biological risks through DNA synthesis screening, BWC strengthening, the Global Health Security Index, and international governance initiatives. Recipient of >\$29M from Coefficient Giving (formerly Open Philanthropy).
Quick Assessment
| Dimension | Assessment | Evidence |
|---|---|---|
| Focus Area | Global catastrophic biological risk reduction | DNA synthesis screening, BWC strengthening, AI-bio risks, international governance1 |
| Funding | Well-funded by EA sources + traditional philanthropy | >$29M identified from Coefficient Giving across multiple grants; NTI parent org founded with $250M from Ted Turner23 |
| Policy Influence | Very high | Endorsed Biosecurity Modernization and Innovation Act of 2026; active at BWC meetings; launched IBBIS in Geneva45 |
| Team | Experienced national security leadership | Led by former White House NSC, DoD, and FDA officials6 |
| Key Output | IBBIS, Global Health Security Index, Bio Funders Compact | Spawned an independent international biosecurity org; benchmarks 195 countries78 |
| Key Concern | Leadership transition period | VP Jaime Yassif stepped down end of 2025; NTI-wide CEO transition to Christine Wormuth910 |
Overview
NTI | bio (stylized as "NTI | bio") is the Global Biological Policy and Programs division of the Nuclear Threat Initiative (NTI), a nonprofit, nonpartisan global security organization headquartered in Washington, D.C. NTI was founded in January 2001 by former U.S. Senator Sam Nunn and CNN founder/philanthropist Ted Turner, who pledged $250 million to support the organization.3
While NTI is best known for its nuclear security work, the biological program has become one of the most influential institutional actors in the biosecurity field. NTI | bio works to reduce global catastrophic biological risks through four strategic approaches:11
- Preventing misuse of biotechnology by individuals or groups
- Identifying urgent solutions for preventing and responding to high-consequence biological events
- Addressing root causes of bioweapons development by states and sophisticated actors
- Enhancing political will among government and private sector leaders
Coefficient Giving identifies NTI | bio as among the "highest-impact biosecurity organizations" in the world.2 Founders Pledge has recommended NTI | bio as a high-impact giving opportunity in the biosecurity space.12
History
NTI Founding (2001)
The Nuclear Threat Initiative was announced at the National Press Club on January 8, 2001, by Sam Nunn, Ted Turner, and former Deputy Secretary of Energy Charles B. Curtis. Turner's concern that "the threat from nuclear weapons had fallen off most people's radar screens after the end of the Cold War" motivated the founding. The organization initially focused on nuclear threats but expanded its mandate to include biological and emerging technology threats.3
Building NTI | bio (2016-2020)
Beth Cameron, Ph.D., joined NTI in 2017 to lead the biological policy program. Cameron had previously served as Senior Director for Global Health Security and Biodefense on the White House National Security Council, where she helped develop and launch the Global Health Security Agenda. Under her leadership, NTI | bio received its first major Coefficient Giving grant of $6 million in 2018 to develop new initiatives to curb global catastrophic biological risks.613
Cameron later departed to serve in the Biden-Harris administration's National Security Council.14
Jaime Yassif Era (2018-2025)
Jaime Yassif, Ph.D., was named Vice President of Global Biological Policy and Programs. During her tenure, she recommended and managed approximately $40 million in biosecurity grants, which she described as having "rebuilt the field." Key accomplishments under her leadership included:9
- Development of new biosecurity programming at leading think tanks
- Establishment of the Global Health Security Index
- Launch of the International Biosecurity and Biosafety Initiative for Science (IBBIS)
- Creation of the Bio Funders Compact with CEPI
- Expansion of the AIxBio Forum addressing AI-biology convergence risks
Yassif stepped down from her VP role at the end of 2025 and continues as a Senior Advisor/consultant to NTI.9
Leadership Transition (2025-Present)
In late 2025, NTI underwent a significant leadership transition. Ernest Moniz, who had served as CEO since 2017 (succeeding Nunn), stepped down alongside President and COO Joan Rohlfing. Christine E. Wormuth, who served as the 25th Secretary of the U.S. Army (the first woman to hold the position), became NTI's third President and CEO effective November 17, 2025. Moniz remains as Co-Chair of the Board alongside Nunn and Turner.10
Key Programs and Initiatives
International Biosecurity and Biosafety Initiative for Science (IBBIS)
IBBIS is an independent organization based in Geneva, Switzerland, that NTI | bio established and launched in 2024. IBBIS is dedicated to strengthening international biosecurity norms and developing innovative tools to prevent misuse of biotechnology.5
IBBIS's initial focus is on preventing misuse of DNA synthesis technology. Its first major product is the Common Mechanism, a software tool enabling DNA synthesis providers to screen orders and customers to ensure that the building blocks of dangerous pathogens do not reach malicious actors. This addresses a critical gap: according to the Global Health Security Index, 94% of countries have no national-level oversight measures for dual-use research.57
Global Health Security Index (GHS Index)
Launched in 2019, the GHS Index is the first comprehensive assessment of health security capabilities across 195 countries. Developed in collaboration with the Johns Hopkins Center for Health Security and The Economist Intelligence Unit, and funded by a $3.56 million Coefficient Giving grant, the Index tracks international pandemic preparedness, assesses compliance with international standards, and identifies capability gaps.715
Bio Funders Compact
Launched in 2024 at the Global Health Security Conference in Sydney, Australia, the Bio Funders Compact is a partnership between NTI | bio and the Coalition for Epidemic Preparedness Innovations (CEPI). The Compact incorporates biosecurity considerations into the bioscience research funding process, aiming to ensure that life science research funding includes safeguards against accidental or intentional misuse.8
Next Generation for Biosecurity
This program develops cohorts of early-career professionals (ages 18-35) in biosecurity and supports their active participation in high-profile international meetings, including the Biological Weapons Convention and Global Health Security Network Conference. The program runs annual competitions and delegation programs, building a network of next-generation biosecurity leaders.16
AIxBio Global Forum
NTI | bio convened the first International AI-Bio Forum in 2024, bringing together biosecurity professionals, AI experts, and policymakers from organizations including Anthropic and Google DeepMind, as well as representatives from China, India, Nigeria, the U.K., and the U.S. The Forum addresses risks at the convergence of artificial intelligence and the life sciences, where AI agents are "progressing rapidly in their ability to understand scientific literature, generate hypotheses, design experiments, and interpret data."17
Biological Weapons Convention (BWC) Strengthening
NTI | bio is a leading non-governmental voice for strengthening the BWC, the international treaty banning biological weapons. Key activities include:4
- Hosting side events at BWC working group sessions
- Convening experts to enhance transparency measures for bioscience research
- Proposing tech-driven solutions to modernize BWC compliance
- Championing improved confidence-building measures to reduce suspicion between states
- Supporting the establishment of internationally recognized assessment processes modeled after Joint External Evaluations
Biosecurity Innovation and Risk Reduction Initiative (BIRRI)
Launched in 2018 in Cambridge, Massachusetts, BIRRI is a multi-year project that identifies, develops, and promotes concrete actions to reduce global catastrophic biological risks associated with technology advances. This initiative spawned IBBIS and continues to serve as a platform for developing biosecurity innovation.18
Africa CDC Partnership
NTI | bio partnered with the Africa Centres for Disease Control and Prevention (Africa CDC) to build biosafety and biosecurity capacity across multiple African regions. The partnership organized training programs for experts across Eastern, Western, Central, Northern, and Southern Africa, reaching hundreds of professionals from dozens of countries.19
Policy Advocacy
Biosecurity Modernization and Innovation Act of 2026
NTI endorsed this bipartisan legislation led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). The Act would:20
- Require DNA synthesis screening: Gene synthesis providers must screen orders and customers for dangerous pathogens
- Establish an innovation hub: Brings together commercial, academic, and government stakeholders to develop biosecurity-by-design solutions
- Create a governance sandbox at NIST: Enables testing of biosecurity tools and flexible policymaking
- Strengthen federal oversight: Streamlines oversight of dual-use bioscience and biotechnology R&D
Leadership and Key Personnel
Current and Former Leadership
NTI | bio Advisory Group
The Advisory Group is chaired by Dr. Margaret Hamburg, former Commissioner of the U.S. Food and Drug Administration. The group provides strategic guidance on NTI | bio's work to reduce global catastrophic biological risks.21
Funding
Coefficient Giving Grants (Biosecurity-Related)
| Grant | Amount | Period | Purpose |
|---|---|---|---|
| Biosecurity Program Support | $6,000,000 | 2018 (3 years) | Initial biosecurity program development13 |
| Global Health Security Index | $3,556,773 | 2018 (2 years) | GHS Index with Johns Hopkins and EIU15 |
| GCBR Reduction Projects | $1,904,942 | 2019 (3 years) | Projects to reduce global catastrophic biological risks22 |
| Biosecurity Program Support | $8,000,000 | Feb 2020 (3 years) | Biosecurity program expansion23 |
| COVID-19 Biosecurity | $500,000 | 2020 | Support for NTI's COVID-19 work24 |
| GCBR Reduction | $1,250,000 | 2021 (2 years) | Work on reducing global catastrophic biological risks25 |
| Biosecurity Program Support | $7,831,500 | 2023 (3 years) | Gene synthesis safeguards, BWC strengthening, field building2 |
| Total identified | >$29,043,215 |
Other Funding Sources
NTI's parent organization receives funding from diverse sources including foundations, governments, and individual donors. Ted Turner's initial $250 million pledge provided the organization's foundational capital. NTI publishes annual financial reports and impact reports on its website.26
Relationship to AI Safety and the EA Community
NTI | bio sits at the intersection of traditional security policy and the effective altruism biosecurity community. Several connections are notable:
- Coefficient Giving has been NTI | bio's largest identified funder for biosecurity work, directing over $29 million toward the program
- Founders Pledge has recommended NTI | bio as a high-impact biosecurity charity12
- NTI | bio's work on AI-bio convergence through the AIxBio Forum directly addresses concerns about AI systems enabling biological threats, connecting to broader AI misuse risk frameworks
- The Next Generation for Biosecurity program has been promoted in EA career communities including 80,000 Hours
- NTI | bio's DNA synthesis screening work (via IBBIS) complements SecureBio's SecureDNA initiative
- Jaime Yassif appeared on the 80,000 Hours podcast to discuss "safeguarding bioscience to prevent catastrophic lab accidents and bioweapons development"27
Criticisms and Limitations
Leadership Turnover
The simultaneous departure of both the NTI CEO (Moniz) and the NTI | bio VP (Yassif) in 2025 creates uncertainty about program continuity and strategic direction during a critical period for biosecurity policy.
Traditional Security Orientation
NTI's roots in nuclear threat reduction mean the organization approaches biological risks primarily through a state security and international governance lens. This may underweight non-state actor risks and emerging technology threats that don't fit traditional arms control frameworks.
Institutional Speed vs. Technology Pace
International governance mechanisms like the BWC and the Global Health Security Agenda operate on multi-year timescales, while advances in AI and biotechnology are accelerating rapidly. NTI | bio's emphasis on institutional solutions faces the challenge of keeping pace with technological change.
Key Uncertainties
Key Questions
- ?Will NTI | bio maintain its strategic direction and Coefficient Giving funding through the 2025 leadership transition?
- ?Can IBBIS's Common Mechanism for DNA synthesis screening achieve widespread international adoption before benchtop synthesis devices become prevalent?
- ?Will the BWC strengthening process produce meaningful compliance mechanisms, or remain aspirational?
- ?How effectively can the AIxBio Forum translate into binding governance for AI-biology convergence risks?
- ?Does the Biosecurity Modernization and Innovation Act of 2026 have realistic prospects for passage?
Sources
Footnotes
-
NTI | bio Program Page — NTI | bio Program Page - Program overview ↩
-
Coefficient Giving - NTI Biosecurity Program Support 2023 — Coefficient Giving - NTI Biosecurity Program Support 2023 - $7.83M grant ↩ ↩2 ↩3
-
Nuclear Threat Initiative - Wikipedia — Nuclear Threat Initiative - Wikipedia - Founding history ↩ ↩2 ↩3
-
NTI at the BWC: Urging Collective Action — NTI at the BWC: Urging Collective Action - BWC engagement ↩ ↩2
-
IBBIS Program Page — IBBIS Program Page - IBBIS overview ↩ ↩2 ↩3
-
Citation rc-253b (data unavailable — rebuild with wiki-server access) ↩ ↩2
-
Citation rc-6f00 (data unavailable — rebuild with wiki-server access) ↩ ↩2 ↩3
-
Bio Funders Compact — Bio Funders Compact - Compact launch ↩ ↩2
-
Citation rc-1915 (data unavailable — rebuild with wiki-server access) ↩ ↩2 ↩3
-
NTI Board Announces 2025 Leadership Transition — NTI Board Announces 2025 Leadership Transition - Wormuth appointment ↩ ↩2
-
Founders Pledge - NTI Bio Assessment — Founders Pledge - NTI Bio Assessment - Strategic approach ↩
-
Founders Pledge - Biosecurity Recommendations — Founders Pledge - Biosecurity Recommendations - Charity recommendation ↩ ↩2
-
Coefficient Giving $6M Grant to NTI — Coefficient Giving $6M Grant to NTI - Initial major grant ↩ ↩2
-
Statement on Beth Cameron Appointment to Biden-Harris NSC — Statement on Beth Cameron Appointment to Biden-Harris NSC - Cameron departure ↩
-
Coefficient Giving - NTI Global Health Security Index — Coefficient Giving - NTI Global Health Security Index - GHS Index grant ↩ ↩2
-
Next Generation for Biosecurity — Next Generation for Biosecurity - Program overview ↩
-
AIxBio Global Forum — AIxBio Global Forum - Forum overview ↩
-
Biosecurity Innovation and Risk Reduction Initiative — Biosecurity Innovation and Risk Reduction Initiative - BIRRI overview ↩
-
NTI | bio and Africa CDC Partnership — NTI | bio and Africa CDC Partnership - Africa partnership ↩
-
Citation rc-4e86 (data unavailable — rebuild with wiki-server access) ↩
-
Margaret Hamburg NTI Profile — Margaret Hamburg NTI Profile - Advisory group chair ↩
-
Coefficient Giving - NTI GCBR Projects — Coefficient Giving - NTI GCBR Projects - GCBR grant ↩
-
Coefficient Giving - NTI Biosecurity Support Feb 2020 — Coefficient Giving - NTI Biosecurity Support Feb 2020 - $8M grant ↩
-
Coefficient Giving - NTI Biosecurity Support — Coefficient Giving - NTI Biosecurity Support - COVID grant ↩
-
Coefficient Giving - NTI GCBR Reduction 2021 — Coefficient Giving - NTI GCBR Reduction 2021 - 2021 grant ↩
-
NTI Financials — NTI Financials - Financial transparency ↩
-
80,000 Hours Podcast - Jaime Yassif — 80,000 Hours Podcast - Jaime Yassif - Podcast interview ↩
References
“The Compact incorporates biosecurity into the bioscience research funding process to safeguard life science research from accidental or intentional misuse.”
The source mentions the Bio Funders Compact but does not mention IBBIS or the Global Health Security Index. It also does not say that the Compact spawned an independent international biosecurity org or that it benchmarks 195 countries.
“NTI launched IBBIS and the international Common Mechanism for DNA synthesis screening in 2024, and established the organization’s headquarters in Geneva, Switzerland.”
unsupported: Endorsed Biosecurity Modernization and Innovation Act of 2026 unsupported: active at BWC meetings minor_issues: launched IBBIS in Geneva (launched in 2024, headquartered in Geneva)
“The Global Health Security (GHS) Index is an assessment and benchmarking of health security and related capabilities across 195 countries.”
The source mentions IBBIS and Bio Funders Compact, but not as key outputs of the Global Health Security Index. The source does not mention that the Global Health Security Index spawned an independent international biosecurity org.
“The legislation advances three core objectives essential to safeguarding innovation: Strengths DNA synthesis sequence and customer screening as a near-term risk-reduction measure Establishes an innovation hub within the U.S. government that brings together commercial, academic, and government stakeholders to develop, test, and deploy real-world solutions that embed biosecurity by design Streamlines and strengthens federal oversight of dual-use bioscience and biotechnology research and development to protect against accidental or deliberate harmful activities, forming core pillars of a comprehensive national biosafety and biosecurity strategy.”
“Dr. Cameron most recently served as the Senior Director for Global Health Security and Biodefense on the White House National Security Council staff, where she was instrumental in developing, launching, and implementing the Global Health Security Agenda.”
The claim mentions 'FDA officials', but the source does not explicitly mention the FDA. The source mentions officials from the White House NSC and DoD.
“NTI’s biosecurity team (abbreviated as “NTI | bio”) has four main approaches to reducing global catastrophic risks from biological events.”
The source does not list the four strategic approaches that NTI | bio uses to reduce global catastrophic biological risks.
“NTI | bio convened the annual Biosecurity Innovation and Risk Reduction Initiative (BIRRI) meeting from May 31 to June 2 at Downing College in Cambridge, United Kingdom.”
“Jaime Yassif, PhD serves a consultant to NTI, providing senior counsel to the NTI | bio team, having stepped down from her role as NTI | bio vice president at the end of 2025.”
The source does not mention Christine Wormuth as the NTI-wide CEO. The source only mentions Jaime Yassif stepping down from her role as NTI vice president at the end of 2025.
“Beth Cameron, PhD “NTI’s Vice President for Global Biological Policy and Programs, Beth Cameron, PhD, has been asked to rebuild the National Security Council’s Office of Global Health Security and Biodefense, where she will serve as senior director and advance the Biden Administration’s agenda on global health security.”
“NTI | bio’s multi-faceted work in this area includes building a stronger case for decision-makers to prioritize action to counter catastrophic biological risks; establishing new forums focused on preventing the development and use of biological weapons by powerful actors; strengthening the Biological Weapons Convention; and developing innovative solutions for early detection and rapid response.”
“NTI's 2024 Impact Report, What Does It Take to Build a Safer World?, details the organization’s accomplishments in reducing global nuclear and biological threats and addressing the benefits and risks associated with artificial intelligence and emerging technologies.”
“NTI | bio convened a workshop on “Disincentivizing State Bioweapons Development and Use” a week ahead of the Biological Weapons Convention Working Group meetings in Geneva, Switzerland.”
WRONG ATTRIBUTION: The claim that NTI endorsed the Biosecurity Modernization and Innovation Act of 2026 is not supported by the source. FABRICATED DETAILS: The claim that NTI launched IBBIS in Geneva is not supported by the source.
“In addition to the competition, NTI | bio develops cohorts of rising leaders in biosecurity and supports their active participation in high-profile, international meetings, such as the Biological Weapons Convention, the Global Health Security Network Conference to facilitate networking and educational opportunities.”
“The AIxBio Global Forum provides a platform for international experts, policymakers, and other key stakeholders to identify and reduce biosecurity risks associated with the convergence of artificial intelligence (AI) and the life sciences.”
The source does not mention AI agents progressing in their ability to understand scientific literature, generate hypotheses, design experiments, and interpret data.
“After years of dedicated service to NTI’s mission of delivering innovative solutions to reducing nuclear, biological and emerging technology threats, Ernest J. Moniz, co-chair and CEO of the Nuclear Threat Initiative (NTI), and Joan Rohlfing, president and COO of NTI, will step down from their roles in 2025.”
The source does not mention Jaime Yassif stepping down. The source does not mention Christine Wormuth as the NTI-wide CEO transition.
“The Open Philanthropy Project grant will allow NTI to develop new initiatives to curb global catastrophic biological risks, catalyze international biosecurity norms and innovation, enhance biosurveillance for emerging threats, and advocate for measurable biosecurity commitments as an integral component of the Global Health Security Agenda.”
“NTI | bio) partnered with the Africa Centres for Disease Control and Prevention (Africa CDC) to sponsor a series of trainings for nearly 100 experts from 14 countries in the Eastern African region with the goal of reducing accidental and deliberate biological risks, including those associated with the COVID-19 pandemic.”
The source only mentions training programs for experts in Eastern Africa, not Western, Central, Northern, and Southern Africa. The source specifies 'nearly 100 experts from 14 countries' not 'hundreds of professionals from dozens of countries'.
“Jaime Yassif on safeguarding bioscience to prevent catastrophic lab accidents and bioweapons development | 80,000 Hours”